Refine Your Search

  • Solutions

  • Therapeutic Areas

  • Resource Type

Informing Pediatric Drug Development: A Selection from Certara’s Best of Blogs

A selection of short essays by Certara’s pediatric drug development experts. Learn about our technologies and strategies for pediatric drug development to inform dose selection, including PK/PD simulations using sparse data analysis and our Simcyp Pediatric Simulator. Certara’s regulatory writing consultancy, Synchrogenix, also offer regulatory strategy for pediatrics.

Author(s): Alice Ke, Ellen Leinfuss, Martin Beliveau, Nastya Kassir, Suzanne Minton
Therapeutic Area: Pediatrics, Rare/Orphan Disease
More Info

Certara’s Best of Blogs 2015

A selection of short essays from our blog, written to empower our customers with biosimulation and regulatory writing solutions in order to help them solve the toughest drug development problems. Certara staff contributions range in topic from pharmacometrics to systems biology to the growing importance of regulatory writing.

Author(s): Alice Ke, Ana Henry, David Hermann, Debra Fontana, Ellen Leinfuss, Helen Humphries, Iain Gardner, Keith Kleeman, Kelley Hill, Kelley Kendle, Kevin Feng, Kim Green, Krishna Machavaram, Mark Lovern, Martin Beliveau, Masoud Jamei, Michael Eckstut, Mohamad-Samer Mouksassi, Nastya Kassir, Nathalie Gosselin, Nikunjkumar Patel, Steve Sibley, Steve Toon, Suzanne Minton, Trevor Johnson, Zoe Barter
More Info

How Modeling and Simulation Technology Could Save Us from the Zombie Apocalypse

Skeptical at the idea of ravenous brain-eating undead? You don’t have to take my word for it. The Centers for Disease Control and Prevention (CDC) Office of Public Health Preparedness and Response recognizes this threat. Their Zombie Preparedness website provides information on getting ready for all kinds of disasters. Modeling and simulation (M&S) technology can […]

Solution: PK/PD Modeling & Simulation
Therapeutic Area: Infectious Disease
More Info

Using Modeling and Simulation to Quantify the PK of an Anti-HIV Drug for Babies

As a scientist at Certara and proud Dad to my three kids, pediatric drug development is a topic that is near to my heart. Clearly, children are not just “small adults.” They require special consideration for their distinct physiology during drug development. Likewise, for ethical reasons, it is important to minimize children’s exposure to experimental […]

Solution: PK/PD Modeling & Simulation
Therapeutic Area: Infectious Disease, Pediatrics
More Info